Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
US10905682B2 · kind B2 · utility
0Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2016 |
| Grant date | Feb 2, 2021 |
| Priority date | — |
| Expiry date | Dec 1, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0078
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating one or more symptoms of COPD comprising administering to an in need of treatment a therapeutically effect amount of one or more mitochondrial iron chelators. The mitochondrial iron chelator can be deferiprone. Compostions comprising mitochondrial iron chelators suitable for administration are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.